In patients with T1-2 oropharyngeal cancer and low-volume neck disease, adding chemotherapy to radiotherapy does not improve overall survival, according to a new study.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/who-benefits-chemoradiotherapy-early-stage-opscc-2025a1000nhk?src=rss
Author :
Publish date : 2025-09-05 06:42:00
Copyright for syndicated content belongs to the linked Source.
